Clinical Trials Browser

OTHER × Liver Diseases × tislelizumab × Clear all

NCT04627012 2024-03-06

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases